406 related articles for article (PubMed ID: 8416737)
21. Combined polymerase chain reaction methods to detect c-myc/IgH rearrangement in childhood Burkitt's lymphoma for minimal residual disease analysis.
Busch K; Borkhardt A; Wössmann W; Reiter A; Harbott J
Haematologica; 2004 Jul; 89(7):818-25. PubMed ID: 15257933
[TBL] [Abstract][Full Text] [Related]
22. [Epstein-Barr virus and Burkitt's lymphoma].
Joab I
Med Trop (Mars); 1999; 59(4 Pt 2):499-502. PubMed ID: 10901854
[TBL] [Abstract][Full Text] [Related]
23. Conditioned tumorigenicity of activated oncogenes.
Klein G; Klein E
Cancer Res; 1986 Jul; 46(7):3211-24. PubMed ID: 3011242
[TBL] [Abstract][Full Text] [Related]
24. Dok1 expression and mutation in Burkitt's lymphoma cell lines.
Lee S; Huang H; Niu Y; Tommasino M; Lenoir G; Sylla BS
Cancer Lett; 2007 Jan; 245(1-2):44-50. PubMed ID: 16338067
[TBL] [Abstract][Full Text] [Related]
25. Wild-type p53 induces apoptosis in a Burkitt lymphoma (BL) line that carries mutant p53.
Ramqvist T; Magnusson KP; Wang Y; Szekely L; Klein G; Wiman KG
Oncogene; 1993 Jun; 8(6):1495-500. PubMed ID: 8502475
[TBL] [Abstract][Full Text] [Related]
26. [Molecular analysis in Argentinian patients with Burkitt's lymphoma].
Gutiérrez MI; Barriga F; Díez B; Larripa I; Magrath I
Sangre (Barc); 1990 Feb; 35(1):10-4. PubMed ID: 2159189
[TBL] [Abstract][Full Text] [Related]
27. Insertion of c-Myc into Igh induces B-cell and plasma-cell neoplasms in mice.
Park SS; Kim JS; Tessarollo L; Owens JD; Peng L; Han SS; Tae Chung S; Torrey TA; Cheung WC; Polakiewicz RD; McNeil N; Ried T; Mushinski JF; Morse HC; Janz S
Cancer Res; 2005 Feb; 65(4):1306-15. PubMed ID: 15735016
[TBL] [Abstract][Full Text] [Related]
28. The in vivo binding site for oncoprotein c-Myc in the promoter for Epstein-Barr virus (EBV) encoding RNA (EBER) 1 suggests a specific role for EBV in lymphomagenesis.
Niller HH; Salamon D; Ilg K; Koroknai A; Banati F; Bauml G; Rucker O; Schwarzmann F; Wolf H; Minarovits J
Med Sci Monit; 2003 Jan; 9(1):HY1-9. PubMed ID: 12552250
[TBL] [Abstract][Full Text] [Related]
29. Phenylbutyrate induces cell differentiation and modulates Epstein-Barr virus gene expression in Burkitt's lymphoma cells.
Bar-Ner M; Thibault A; Tsokos M; Magrath IT; Samid D
Clin Cancer Res; 1999 Jun; 5(6):1509-16. PubMed ID: 10389940
[TBL] [Abstract][Full Text] [Related]
30. Level of MYC overexpression in pediatric Burkitt's lymphoma is strongly dependent on genomic breakpoint location within the MYC locus.
Wilda M; Busch K; Klose I; Keller T; Woessmann W; Kreuder J; Harbott J; Borkhardt A
Genes Chromosomes Cancer; 2004 Oct; 41(2):178-82. PubMed ID: 15287031
[TBL] [Abstract][Full Text] [Related]
31. Lack of mutagenicity and clastogenicity of PNAEmu-NLS targeted to a regulatory sequence of the translocated c-myc oncogene in Burkitt's lymphoma.
Boffa LC; Menichini P; Bolognesi C; Cutrona G; Roncella S; Damonte GL; Millo E; Mariani MR; Matis S; Russo D; Ciliutti P; Ferrarini M
Mutat Res; 2007 Apr; 628(2):129-37. PubMed ID: 17267263
[TBL] [Abstract][Full Text] [Related]
32. Cationic lipids reduce time and dose of c-myc antisense oligodeoxynucleotides required to specifically inhibit Burkitt's lymphoma cell growth.
Williams SA; Chang L; Buzby JS; Suen Y; Cairo MS
Leukemia; 1996 Dec; 10(12):1980-9. PubMed ID: 8946941
[TBL] [Abstract][Full Text] [Related]
33. The distinction between Burkitt lymphoma and diffuse large B-Cell lymphoma with c-myc rearrangement.
Nakamura N; Nakamine H; Tamaru J; Nakamura S; Yoshino T; Ohshima K; Abe M
Mod Pathol; 2002 Jul; 15(7):771-6. PubMed ID: 12118116
[TBL] [Abstract][Full Text] [Related]
34. Selective expression of one c-myc allele in two human myeloma cell lines.
Kuehl WM; Brents LA; Chesi M; Bergsagel PL
Cancer Res; 1996 Oct; 56(19):4370-3. PubMed ID: 8813127
[TBL] [Abstract][Full Text] [Related]
35. c-myc expression is activated by the immunoglobulin kappa-enhancers from a distance of at least 30 kb but not by elements located within 50 kb of the unaltered c-myc locus in vivo.
Mautner J; Behrends U; Hörtnagel K; Brielmeier M; Hammerschmidt W; Strobl L; Bornkamm GW; Polack A
Oncogene; 1996 Mar; 12(6):1299-307. PubMed ID: 8649832
[TBL] [Abstract][Full Text] [Related]
36. A human Burkitt's lymphoma cell line carrying t(8;22) and t(14;18) translocations.
Kiefer T; Schüler F; Knopp A; Wimmer M; Hirt C; Schaefer HE; Dölken G
Ann Hematol; 2007 Nov; 86(11):821-30. PubMed ID: 17622530
[TBL] [Abstract][Full Text] [Related]
37. Structure-activity relationship of 17 structural analogues of n-butyric acid upon c-myc expression.
Rottleb C; Hall C; Bornkamm GW; Polack A
Int J Cancer; 1996 Sep; 67(5):724-9. PubMed ID: 8782665
[TBL] [Abstract][Full Text] [Related]
38. Oncogene expression and immunoglobulin synthesis in a North American Burkitt (NAB-2) lymphoma cell line with a 8;22 chromosome translocation.
Popescu NC; Dahlberg JE; Ablashi DV; Monastier M; Bona CA; DiPaolo JA; Hooper WC; Swan DC
Oncogene Res; 1990; 5(4):295-303. PubMed ID: 1697668
[TBL] [Abstract][Full Text] [Related]
39. What is Burkitt's lymphoma?
Wright DH
J Pathol; 1997 Jun; 182(2):125-7. PubMed ID: 9274520
[TBL] [Abstract][Full Text] [Related]
40. Frequent aberrations of chromosome 8 in aggressive B-cell non-Hodgkin lymphoma.
Pienkowska-Grela B; Witkowska A; Grygalewicz B; Rymkiewicz G; Rygier J; Woroniecka R; Walewski J
Cancer Genet Cytogenet; 2005 Jan; 156(2):114-21. PubMed ID: 15642390
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
